Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWalker Crips Regulatory News (WCW)

  • This share is currently suspended. It was suspended at a price of 13.50
  • There is currently no data for WCW

Board and Management Changes

9 Jul 2025 13:15

RNS Number : 4003Q
Walker Crips Group plc
09 July 2025
 

9 July 2025

 

Walker Crips Group plc

("Walker Crips" or the "Company")

 

Board and Management Changes

 

Walker Crips Group PLC is pleased to announce a number of changes to the composition of its Board of Directors (the "Board") and executive leadership team as part of a strategic reorganisation to support the Company's growth and operational resilience.

 

As previously announced, Jo Welman was appointed as Non-Executive Chair on 31 March 2025, and Linus Lim and Mark Nelligan joined the Board as Non-Executive Directors on 6 February and 25 April 2025 respectively.

 

Following a comprehensive review of the Company's senior leadership structure, the Company will implement a joint leadership model with the appointment of two Joint Chief Executive Officers. Both appointments will be Executive Directors of the Company and members of the Board.

 

Christian Dougal, currently Chief Risk and Compliance Officer, will be appointed Joint CEO, responsible for the Company's administrative functions, including Finance, HR, Risk & Compliance, and IT Support. Christian joined the Company in July 2024, and his leadership has been instrumental in addressing the Company's regulatory priorities.

 

Sean Lam, who currently serves as CEO, will assume the title of Joint CEO and will continue to oversee the Company's commercial operations. He will retain his role as CEO of Walker Crips Investment Management ("WCIM").

 

 

Walker Crips confirms that there are no details that require disclosure under UK Listing Rule 6.4.8R in respect of Christian Dougal.

 

Jo Welman, Chair of Walker Crips, commented:

 

"These changes mark a critical step in building a leadership platform that reflects the scale and ambition of our strategy. Christian brings operational discipline and regulatory depth, while Sean's commercial instincts and leadership continuity will be invaluable as we pursue our growth objectives. I would also like to thank the entire leadership team for their commitment to positioning the Company for long-term success."

 

For further information, please contact:

 

Walker Crips Group plc

Craig Harrison, Media Relations

Tel: +44 (0)20 3100 8000

Singer Capital Markets

Charles Leigh-Pemberton / Asha Chotai

Tel: +44 (0)20 7496 3000

 

 

Further information on Walker Crips Group is available on the Company's website: www.walkercrips.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABBGDRCUGDGUC
Date   Source Headline
25th Nov 20257:00 amRNSForm 8.3 - Walker Crips Group PLC
24th Nov 20257:47 amRNSDisclosure Table
24th Nov 20257:00 amRNSRecommended Cash Offer for Walker Crips Group PLC
24th Nov 20257:00 amRNSWorking Capital Loan Extension & Trading Update
29th Sep 20255:04 pmRNSResult of AGM
3rd Sep 20255:45 pmRNSDirectorate Change
14th Aug 20255:30 pmRNSDirectorate Change
31st Jul 20255:45 pmRNSWorking Capital Loan Drawdown Facility
31st Jul 20255:45 pmRNSFinal Results
9th Jul 20251:15 pmRNSBoard and Management Changes
28th Apr 20255:45 pmRNSAppointment of Non-Executive Director
7th Apr 202510:36 amRNSDirector Declaration
31st Mar 20255:45 pmRNSAppointment of Non-Executive Chairman
12th Feb 20254:32 pmRNSDirector Declaration
6th Feb 20255:45 pmRNSDirectorate Changes
27th Dec 20249:45 amRNSResults for the six months ended 30 September 2024
27th Nov 20247:30 amRNSDirector/PDMR Shareholding
27th Sep 202412:00 pmRNSResult of AGM
31st Jul 20241:00 pmRNSFinal results for the year ended 31 March 2024
14th Jun 202410:01 amRNSResignation of Non-executive Director
28th Dec 202312:15 pmRNSResults for the six months ended 30 September 2023
27th Sep 20232:07 pmRNSResult of AGM
31st Jul 20236:25 pmRNSFinal results for the year ended 31 March 2023
23rd Dec 202210:00 amRNSHalf-year Report
11th Oct 20225:19 pmRNSDirector/PDMR Shareholding
29th Sep 20221:37 pmRNSResult of AGM
29th Jul 20223:01 pmRNSFinal Results
9th Jun 20223:28 pmRNSHolding(s) in Company
26th Apr 20222:17 pmRNSDirector/PDMR Shareholding
29th Mar 20223:25 pmRNSDirector/PDMR Shareholding
16th Dec 20217:00 amRNSHalf-year Report
28th Sep 20211:12 pmRNSResult of AGM
16th Sep 20219:06 amRNSSecond Price Monitoring Extn
16th Sep 20219:00 amRNSPrice Monitoring Extension
20th Aug 20213:40 pmRNSFinal Results
28th Jan 20215:39 pmRNSDirector/PDMR Shareholding
27th Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 202112:03 pmRNSDirector/PDMR Shareholding
22nd Dec 20203:00 pmRNSExternal Auditor Appointment
27th Nov 20209:34 amRNSHalf-year Report - Replacement
27th Nov 20207:00 amRNSHalf-year Report
28th Oct 20209:24 amRNSDirector/PDMR Shareholding
2nd Oct 20203:55 pmRNSDirector/PDMR Shareholding
28th Sep 20207:00 amRNSDirector/PDMR Shareholding
18th Sep 20205:57 pmRNSDirector/PDMR Shareholding - Replacement
18th Sep 20204:48 pmRNSDirector/PDMR Shareholding
11th Sep 202010:01 amRNSDirector/PDMR Shareholding
9th Sep 202012:30 pmRNSResult of AGM
19th Aug 202012:25 pmRNSDirector/PDMR Shareholding
4th Aug 20202:59 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.